Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University Health Network, Toronto | OTHER |
Not provided
Not provided
Not provided
Not provided
Driving is a set of complex tasks and requires use of multiple cognitive domains, including attention, planning, and memory. In laboratory studies, the main psychoactive component in cannabis, delta-9-tetrahydrocannabinol (THC), was shown to impair short-term memory, attention, reaction time, tracking, and coordination, resulting, for instance, in significantly more deviations from the lane and increased break latency. Surveys and epidemiological studies suggest that cannabis consumption is associated with increased risks of collision.
The current study aims to evaluate individual driving behavior and performance on various neurocognitive tests and their correlated neural networks while under the influence of cannabis and while sober. The investigators will use the STISIM driving simulator, which is fully MRI compatible, to study brain activation, while participants are performing various driving maneuvers.
The goals of the study are:
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Cannabis - Jean Guy | Experimental | A participant will be administered 1g of Jean Guy strain of cannabis. |
|
| Cannabis - Churchill | Experimental | A participant will be administered 1g of Churchill strain of cannabis. |
|
| Sober | No Intervention | All participants will complete same tasks sober. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Cannabis | Drug | Participants will be assigned to consume one of the cannabis strains and will complete testing immediately after consumption. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in neural activation on fMRI during driving simulation | Neural activation, based on BOLD signal, while completing driving tasks under the influence of cannabis and sober. | 30-60 min after cannabis intake vs sober |
| Measure | Description | Time Frame |
|---|---|---|
| Performance on driving simulator | Number of errors while completing driving tasks (e.g. turning, driving straight, speed maintenance, missed stop signs, etc.) under the influence of cannabis and sober. | 30-60 min after cannabis intake vs sober |
| Performance on cognitive tasks |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Tom Schweizer, PhD | Unity Health Toronto | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University Health Network | Toronto | Ontario | M5G 2C4 | Canada |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D002189 | Marijuana Abuse |
| ID | Term |
|---|---|
| D019966 | Substance-Related Disorders |
| D064419 | Chemically-Induced Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
| ID | Term |
|---|---|
| C587251 | nabiximols |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
Cognitive test battery to assess various driving-related cognitive functions: attention, working memory, visual-spatial processing, processing speed, etc. |
| 60-90 min after cannabis intake vs sober |
| Blood plasma concentration levels of cannabinoids | Concentration levels of THC and CBD throughout the session duration | 10 min and 60 min after cannabis intake |